WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H561363
CAS#: 54-95-5
Description: Pentetrazol, also known as pentylenetetrazole, metrazol, pentetrazol (INN), pentamethylenetetrazol, Corazol, Cardiazol or PTZ, is a non-competitive GABA antagonist. It was formerly used as a drug for circulatory and respiratory stimulation.
Hodoodo Cat#: H561363
Name: Pentetrazol
CAS#: 54-95-5
Chemical Formula: C6H10N4
Exact Mass: 138.09
Molecular Weight: 138.170
Elemental Analysis: C, 52.16; H, 7.30; N, 40.55
Synonym: Pentetrazol; Metrazole; Cardiol; Cardiazol; Pentylenetetrazole;
IUPAC/Chemical Name: 6,7,8,9-Tetrahydro-5H-tetrazolo[1,5-a]azepine
InChi Key: CWRVKFFCRWGWCS-UHFFFAOYSA-N
InChi Code: InChI=1S/C6H10N4/c1-2-4-6-7-8-9-10(6)5-3-1/h1-5H2
SMILES Code: N12C(CCCCC2)=NN=N1
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 138.17 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Urade Y. Neurobiological Basis of Hypersomnia. Sleep Med Clin. 2017 Sep;12(3):265-277. doi: 10.1016/j.jsmc.2017.03.003. Epub 2017 Jun 7. Review. PubMed PMID: 28778226.
2: Radu BM, Epureanu FB, Radu M, Fabene PF, Bertini G. Nonsteroidal anti-inflammatory drugs in clinical and experimental epilepsy. Epilepsy Res. 2017 Mar;131:15-27. doi: 10.1016/j.eplepsyres.2017.02.003. Epub 2017 Feb 9. Review. PubMed PMID: 28212985.
3: Kaminski K. Novel Hybrid Anticonvulsants Derived from Pyrrolidine-2,5-dione Scaffold with Broad Spectrum of Activity in the Preclinical Studies. Curr Top Med Chem. 2017;17(8):858-874. doi: 10.2174/1568026616666160927153025. Review. PubMed PMID: 27697054.
4: Prince DA, Gu F, Parada I. Antiepileptogenic repair of excitatory and inhibitory synaptic connectivity after neocortical trauma. Prog Brain Res. 2016;226:209-27. doi: 10.1016/bs.pbr.2016.03.013. Epub 2016 Apr 30. Review. PubMed PMID: 27323945.
5: Manjarrez-Marmolejo J, Franco-Pérez J. Gap Junction Blockers: An Overview of their Effects on Induced Seizures in Animal Models. Curr Neuropharmacol. 2016;14(7):759-71. Review. PubMed PMID: 27262601; PubMed Central PMCID: PMC5050393.
6: Villalpando-Vargas F, Medina-Ceja L. Sparteine as an anticonvulsant drug: Evidence and possible mechanism of action. Seizure. 2016 Jul;39:49-55. doi: 10.1016/j.seizure.2016.05.010. Epub 2016 May 24. Review. PubMed PMID: 27262285.
7: Wang W, Wang X, Chen L, Zhang Y, Xu Z, Liu J, Jiang G, Li J, Zhang X, Wang K, Wang J, Chen G, Luo J. The microRNA miR-124 suppresses seizure activity and regulates CREB1 activity. Expert Rev Mol Med. 2016 Mar 21;18:e4. doi: 10.1017/erm.2016.3. Review. PubMed PMID: 26996991; PubMed Central PMCID: PMC4836211.
8: Hadera MG, McDonald T, Smeland OB, Meisingset TW, Eloqayli H, Jaradat S, Borges K, Sonnewald U. Modification of Astrocyte Metabolism as an Approach to the Treatment of Epilepsy: Triheptanoin and Acetyl-L-Carnitine. Neurochem Res. 2016 Feb;41(1-2):86-95. doi: 10.1007/s11064-015-1728-5. Epub 2015 Oct 3. Review. PubMed PMID: 26433381.
9: Hadera MG, Eloqayli H, Jaradat S, Nehlig A, Sonnewald U. Astrocyte-neuronal interactions in epileptogenesis. J Neurosci Res. 2015 Jul;93(7):1157-64. doi: 10.1002/jnr.23584. Epub 2015 Mar 18. Review. PubMed PMID: 25782696.
10: Rogawski MA, Tofighy A, White HS, Matagne A, Wolff C. Current understanding of the mechanism of action of the antiepileptic drug lacosamide. Epilepsy Res. 2015 Feb;110:189-205. doi: 10.1016/j.eplepsyres.2014.11.021. Epub 2014 Dec 3. Review. PubMed PMID: 25616473.
11: Heinbockel T, Wang ZJ, Jackson-Ayotunde PL. Allosteric Modulation of GABAA Receptors by an Anilino Enaminone in an Olfactory Center of the Mouse Brain. Pharmaceuticals (Basel). 2014 Dec 17;7(12):1069-90. doi: 10.3390/ph7121069. Review. PubMed PMID: 25525715; PubMed Central PMCID: PMC4276907.
12: Legradi J, el Abdellaoui N, van Pomeren M, Legler J. Comparability of behavioural assays using zebrafish larvae to assess neurotoxicity. Environ Sci Pollut Res Int. 2015 Nov;22(21):16277-89. doi: 10.1007/s11356-014-3805-8. Epub 2014 Nov 18. Review. PubMed PMID: 25399529.
13: Cooper K, Fink M. The chemical induction of seizures in psychiatric therapy: were flurothyl (indoklon) and pentylenetetrazol (metrazol) abandoned prematurely? J Clin Psychopharmacol. 2014 Oct;34(5):602-7. doi: 10.1097/JCP.0000000000000173. Review. PubMed PMID: 25029329.
14: Borowicz KK, Banach M. Antiarrhythmic drugs and epilepsy. Pharmacol Rep. 2014 Aug;66(4):545-51. doi: 10.1016/j.pharep.2014.03.009. Epub 2014 Apr 13. Review. PubMed PMID: 24948053.
15: Fink M. The seizure, not electricity, is essential in convulsive therapy: the flurothyl experience. J ECT. 2014 Jun;30(2):91-3. doi: 10.1097/YCT.0000000000000110. Review. PubMed PMID: 24625714.
16: Amigo I, Kowaltowski AJ. Dietary restriction in cerebral bioenergetics and redox state. Redox Biol. 2014 Jan 11;2:296-304. doi: 10.1016/j.redox.2013.12.021. eCollection 2014. Review. PubMed PMID: 24563846; PubMed Central PMCID: PMC3926116.
17: Martínez-Cué C, Delatour B, Potier MC. Treating enhanced GABAergic inhibition in Down syndrome: use of GABA α5-selective inverse agonists. Neurosci Biobehav Rev. 2014 Oct;46 Pt 2:218-27. doi: 10.1016/j.neubiorev.2013.12.008. Epub 2014 Jan 9. Review. PubMed PMID: 24412222.
18: Alavizadeh SH, Hosseinzadeh H. Bioactivity assessment and toxicity of crocin: a comprehensive review. Food Chem Toxicol. 2014 Feb;64:65-80. doi: 10.1016/j.fct.2013.11.016. Epub 2013 Nov 22. Review. PubMed PMID: 24275090.
19: Guan R, Xu X, Chen M, Hu H, Ge H, Wen S, Zhou S, Pi R. Advances in the studies of roles of Rho/Rho-kinase in diseases and the development of its inhibitors. Eur J Med Chem. 2013;70:613-22. doi: 10.1016/j.ejmech.2013.10.048. Epub 2013 Oct 25. Review. PubMed PMID: 24211637.
20: Ahsan MJ. Semicarbazone analogs as anticonvulsant agents: a review. Cent Nerv Syst Agents Med Chem. 2013 Jun;13(2):148-58. Review. PubMed PMID: 24156314.